5307 NW 35th Court
Plantation, FL 33309
United States
Phone: 954-581-9800
Fax: 954-581-0555
www.imds.com
Imaging Diagnostic Systems, Inc., a development stage medical technology company, engages in the development and testing of a Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography or CTLM). The company is in the process of commercializing the CTLM in certain international markets. CTLM system The CTLM system is a CT-like scanner, but its energy source is a laser beam. CTLM is a new imaging modality offering the potential of molecular functional imaging, which can visualize the process of angiogenesis which may be used to distinguish between benign and malignant tissue. The CTLM is being marketed as an adjunct to mammography to provide the radiologist with additional information to manage the clinical case. The company intends to develop its technology into a family of related products. The CTLM system laser diodes can stimulate fluorescent light emissions when used in conjunction with compounds. When an appropriate fluorescent compound has been introduced into the blood, areas with an abundance of blood vessels, that is the angiogenesis associated with a tumor, may retain a higher concentration of the fluorescent compound. Laser Imager for Lab Animals The company’s Laser Imager for Lab Animals ‘LILA’ program is an optical helical micro-CT scanner in a third-generation configuration. The system was designed to image various compounds, especially green fluorescent protein, derived from the DNA of jellyfish. The LILA scanner is targeted at pharmaceutical developers and researchers who monitor cancer growth and who use multimodality small animal imaging in their clinical research. Markets The company markets CTLM to centers performing x-ray mammography. CTLM Laser Mammography Systems are installed in the following countries: Italy, Germany, Poland, the Czech Republic, the Peoples Republic of China, Malaysia and the United Arab Emirates. Sales and Marketing The company has a major commercial presence in the Peoples Republic of China (PRC). Significant Events In September 2009, Imaging Diagnostic Systems Inc. announced the sale of another CT Laser Mammography system in Asia. The system, which was sold to and installed at the Katherine Women’s Health Center in Malaysia, is being used in patient examinations. The Women’s Health Center would also serve as a training and demonstration site for future customers. Competition The company’s competitors include Advanced Research Technologies, Inc. and Philips Medical Systems. History Imaging Diagnostic Systems, Inc. was founded in 1993.
Why this is a hot stock
- Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The Computed Tomography Laser Mammography (CTLM®) system uses lasers to image the breast in a non-invasive procedure. Unlike x-ray mammography, CTLM images blood hemoglobin and the process of neoangiogenesis or new vessel formation which is often associated with breast cancer.
- CT laser breast imaging is part of the emerging field of optical imaging.
- In a study of over 100 women, including 30 with breast cancer, optical imaging increased sensitivity and specificity of breast cancer detection by more than 90% (Britton Chance, Molecular Imaging, Vol. 2 #2)
- CTLM may provide a brighter future for cancer patients due to earlier diagnosis and treatment. Early visualization of tumors in the evolving process will lead to breast sparing surgery and less trauma to the patient.